Patents-Review.com
ClassID:

21156 ⎘

A61K39/40 - CPC Classification

Classification description:

Medicinal preparations containing antigens or antibodies; Antibodies ; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial

Recent Application in this class:
#1
20260153509
2026-06-04

BORRELIA BURGDORFERI PEPTIDOGLYCAN AS A DIAGNOSTIC AND TARGET FOR THERAPEUTIC INTERVENTION OF LYME DISEASE-RELATED PATHOLOGIES

 #2
20260116956
2026-04-30

ANTIBODY BASED TREATMENT TO REDUCE GUT BACTERIAL GLYCAN AND ASSOCIATED BACTERIA

 #3
20250381260
2025-12-18

FAP2-DERIVED ANTIBODIES AND VACCINES AGAINST FUSOBACTERIUM

 #4
20250368723
2025-12-04

ANTI-O2 ANTIBODIES AND USES THEREOF

 #5
20250304660
2025-10-02

ANTI-SHIGA MONOCLONAL ANTIBODY AND USES THEREOF

 #6
20250295770
2025-09-25

IgY Antibody Compositions and Methods for Treating Avian Species

 #7
20250270298
2025-08-28

MULTIVALENT ANTI-CAMPYLOBACTER ANTIBODIES AND VACCINE

 #8
20250206810
2025-06-26

TREATMENT OF STAPHYLOCOCCUS RELATED DISEASES

 #9
20250066486
2025-02-27

CLEC9A BINDING AGENTS AND USE THEREOF

 #10
20240360224
2024-10-31

CLEC9A BINDING AGENTS AND USE THEREOF

 #11
20240344102
2024-10-17

METHODS AND MEANS FOR THE PRODUCTION OF IG-LIKE MOLECULES

 #12
20240307535
2024-09-19

Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of infections

 #13
20240301041
2024-09-12

ANTI-STAPHYLOCOCCUS ANTIBODIES AND USES THEREOF

 #14
20240216494
2024-07-04

PROTEINS AND IMMUNIZING COMPOSITIONS CONTAINING KLEBSIELLA PROTEINS AND METHODS OF USE

 #15
20240075138
2024-03-07

Peptides and antibodies for the removal of biofilms

 #16
20240042002
2024-02-08

Compositions and methods for the prevention of S. aureus infection

 #17
20240033354
2024-02-01

A BROADLY NEUTRALIZING MOLECULE AGAINST CLOSTRIDIUM DIFFICILE TOXIN B

 #18
20240011986
2024-01-11

BACTERIAL BIOMARKER FOR RHEUMATOID ARTHRITIS AND RELATED MATERIALS AND METHODS

 #19
20230414740
2023-12-28

IMMUNOGENIC COMPOSITIONS

 #20
20230372416
2023-11-23

COMBINATION OF INHALED ANTIBODIES AND IMMUNOMODULATORY AGENTS FOR THE TREATMENT OR PREVENTION OF RESPIRATORY INFECTIONS

 #21
20230355734
2023-11-09

A FACTOR H BINDING PROTEIN B (FHBB) BASED CHIMERIC VACCINE FOR THE PREVENTION AND TREATMENT OF PERIODONTAL DISEASE

 #22
20230346903
2023-11-02

GROUP B STREPTOCOCCUS POLYSACCHARIDE-PROTEIN CONJUGATES, METHODS FOR PRODUCING CONJUGATES, IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATES, AND USES THEREOF

 #23
20230340556
2023-10-26

Methods and means for the production of Ig-like molecules

 #24
20230322907
2023-10-12

ANTI-PCRV ANTIBODIES THAT BIND PCRV, COMPOSITIONS COMPRISING ANTI-PCRV ANTIBODIES, AND METHODS OF USE THEREOF

 #25
20230272054
2023-08-31

COMBINATION THERAPIES FOR THE TREATMENT AND PREVENTION OF BIOFILMS

 #26
20230235030
2023-07-27

Compositions and methods for the removal of biofilms

 #27
20230183330
2023-06-15

FC-REGION VARIANTS WITH IMPROVED PROTEIN A-BINDING

 #28
20230165949
2023-06-01

CLOSTRIDIUM DIFFICILE ANTIGENS

 #29
20230151081
2023-05-18

Cellular factors involved in the cytotoxicity of leukocidins: novel therapeutic targets

 #30
20230125824
2023-04-27

METHOD FOR PRODUCING SERUM COMPOSITION FOR PREVENTING OR TREATING MUCOSARELATED INFECTIOUS DISEASE IN YOUNG MAMMALS, SERUM COMPOSITION PRODUCED THEREBY, AND USE THEREOF

 #31
20230079661
2023-03-16

Anti-O2 antibodies and uses thereof

 #32
20230077855
2023-03-16

Method for the treatment or prevention of infection-related immune conditions using a composition comprising IgM

 #33
20230053458
2023-02-23

METHODS FOR PROVIDING CONTINUOUS THERAPY AGAINST PNAG COMPRISING MICROBES

 #34
20230039109
2023-02-09

ANTIBODY MOLECULES TO CD73 AND USES THEREOF

 #35
20220354950
2022-11-10

TREATMENT AND CONTROL OF BACTERIAL AND FUNGAL DISEASE IN HONEYBEES

 #36
20220289830
2022-09-15

ANTIBODIES SPECIFICALLY RECOGNIZING PSEUDOMONAS PCRV AND USES THEREOF

 #37
20220267418
2022-08-25

ANTIBODY MOLECULE-DRUG CONJUGATES AND USES THEREOF

 #38
20220259294
2022-08-18

Binding moieties for biofilm remediation

 #39
20220251175
2022-08-11

Compositions and methods for treating and preventing infections

 #40
20220227819
2022-07-21

COMPOSITIONS AND METHODS RELATED TO ANTIBODIES THAT NEUTRALIZE COAGULASE ACTIVITY DURING STAPHYLOCOCCUS AUREUS DISEASE

 #41
20220204600
2022-06-30

THERAPEUTIC PROTEIN FORMULATIONS COMPRISING ANTI-DNABII ANTIBODIES AND USES THEREOF

 #42
20220204594
2022-06-30

Compositions and methods for the removal of biofilms

 #43
20220168420
2022-06-02

Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of infections

 #44
20220089700
2022-03-24

Antibodies against clostridium difficile toxins and methods of using the same

 #45
20220072118
2022-03-10

Immunogenic compositions

 #46
20220048979
2022-02-17

Treatment of staphylococcal disorders

 #47
20220047646
2022-02-17

Compositions for management of disorders of the gastrointestinal tract

 #48
20220041695
2022-02-10

METHOD FOR PREVENTING OR TREATING NOSOCOMIAL PNEUMONIA

 #49
20220023339
2022-01-27

Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection

 #50
20210369830
2021-12-02

CLOSTRIDIUM DIFFICILE ANTIGENS

 #51
20210364514
2021-11-25

BORRELIA BURGDORFERI PEPTIDOGLYCAN AS A DIAGNOSTIC AND TARGET FOR THERAPEUTIC INTERVENTION OF LYME DISEASE-RELATED PATHOLOGIES

 #52
20210340228
2021-11-04

METHODS OF TREATING AND PREVENTING STAPHYLOCOCCUS AUREUS INFECTIONS AND ASSOCIATED CONDITIONS

 #53
20210332112
2021-10-28

STABILIZED PERTUSSIS ANTIBODIES WITH EXTENDED HALF-LIFE

 #54
20210330776
2021-10-28

Proteins and immunizing compositions containing proteins and methods of use

 #55
20210299254
2021-09-30

Compositions and methods for treating Crohn's Disease and related conditions and infections

 #56
20210292397
2021-09-23

Compositions and methods for reducing bacterial aggregation

 #57
20210283253
2021-09-16

COMPOSITIONS AND METHODS AGAINST P. AERUGINOSA INFECTIONS

 #58
20210252149
2021-08-19

Composition and Methods for Treating Infectious Agents Using Pathogen-specific Antibodies

 #59
20210238263
2021-08-05

Anti-O2 antibodies and uses thereof

 #60
20210228716
2021-07-29

Peptides and antibodies for the removal of biofilms

 #61
20210155678
2021-05-27

Methods and compositions related to immunizing against lung diseases and conditions

 #62
20210147519
2021-05-20

BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND A STAPHYLOCOCCUS TARGET ANTIGEN AND A COMPLEMENT COMPONENT AND USES THEREOF

 #63
20210145957
2021-05-20

GROUP B STREPTOCOCCUS POLYSACCHARIDE-PROTEIN CONJUGATES, METHODS FOR PRODUCING CONJUGATES, IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATES, AND USES THEREOF

 #64
20210071222
2021-03-11

Methods and means for the production of Ig-like molecules

 #65
20210024637
2021-01-28

Clec9A binding agents comprising a recombinant heavy-chain only antibody (VHH)

 #66
20210009664
2021-01-14

Cellular factors involved in the cytotoxicity of leukocidins: novel therapeutic targets

 #67
20210002353
2021-01-07

Multi-valent hepatitis B virus antigen binding molecules and uses thereof

 #68
20200407429
2020-12-31

Antibodies to surface determinants

 #69
20200399685
2020-12-24

Methods for detection of antibiotic resistant

#70
20200392211
2020-12-17

Methods of treating and preventing infections and associated conditions

 #71
20200392210
2020-12-17

Anti-PcrV antibodies that bind PcrV, compositions comprising anti-PcrV antibodies, and methods of use thereof

 #72
20200377578
2020-12-03

NEUTRALISING ANTIBODIES TO THE MAJOR EXOTOXINS TCDA AND TCDB OF CLOSTRIDIUM DIFFICILE

 #73
20200353081
2020-11-12

Combination of plasma immunoglobulin and antigen-specific immunoglobulin for the modification of the immune system and the treatment or prevention of allergic diseases

 #74
20200330597
2020-10-22

Anti-glucosaminidase passive immunization for infections

 #75
20200316199
2020-10-08

Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of infections

 #76
20200237912
2020-07-30

METHOD FOR THE TREATMENT OR PREVENTION OF INFECTION-RELATED IMMUNE CONDITIONS USING A COMPOSITION COMPRISING IGM

 #77
20200223908
2020-07-16

Method for treating infectious diseases using a composition comprising plasma-derived immunoglobulin M (IgM)

 #78
20200190170
2020-06-18

Binding moieties for biofilm remediation

 #79
20200181244
2020-06-11

Compositions and methods for the therapy and diagnosis of Inflammatory Bowel Disease

 #80
20200157193
2020-05-21

Anti-antibodies and uses thereof

 #81
20200131252
2020-04-30

Compositions and methods for treating and preventing infections

 #82
20200040067
2020-02-06

ANTI-SALMONELLA ANTIBODIES AND USES THEREOF

 #83
20200017909
2020-01-16

Human genetic markers associated with response to treatments that target clostridium difficile toxin B

 #84
20200017897
2020-01-16

Methods and means for the production of ig-like molecules

 #85
20200002409
2020-01-02

Compositions and methods for the removal of biofilms

 #86
20190389927
2019-12-26

CD147 AS RECEPTOR FOR PILUS-MEDIATED ADHESION OF MENINGOCOCCI TO VASCULAR ENDOTHELIA

 #87
20190358325
2019-11-28

Method for the treatment or prevention of infection-related immune conditions using a composition comprising IgM

 #88
20190352378
2019-11-21

Antibodies that modulate immunity to drug resistant and latent MTB infections

 #89
20190336592
2019-11-07

OmpA and Asp14 in vaccine compositions and as diagnostic targets

 #90
20190328859
2019-10-31

CLOSTRIDIUM DIFFICILE ANTIGENS

 #91
20190314501
2019-10-17

Anti-glucosaminidase passive immunization for infections

 #92
20190298872
2019-10-03

Targeted enzymatic degradation of quorum-sensing peptides

 #93
20190284260
2019-09-19

RNA-CODED ANTIBODY

 #94
20190270827
2019-09-05

Passive immunization for infections

 #95
20190247499
2019-08-15

Compositions and methods for treating Crohn's disease and related conditions and infections

 #96
20190247497
2019-08-15

Anti-PD-L1-anti-TIM-3 bispecific antibodies

 #97
20190247438
2019-08-15

Platelet compositions and methods for the delivery of therapeutic agents

 #98
20190234946
2019-08-01

OmpA in vaccine compositions and as diagnostic targets

 #99
20190153078
2019-05-23

Antibodies against toxins and methods of using the same

 #100
20190153076
2019-05-23

DNA Antibody Constructs for Use against Pseudomonas Aeuruginosa

 #101
20190142922
2019-05-16

Group B polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof

 #102
20190135900
2019-05-09

Methods of treating and preventing infections and associated conditions

 #103
20190127457
2019-05-02

Fc-region variants with improved protein A-binding

 #104
20190127449
2019-05-02

Compositions and methods for treating and preventing infections

 #105
20190117753
2019-04-25

OMPA IN VACCINE COMPOSITIONS AND AS DIAGNOSTIC TARGETS

 #106
20190112342
2019-04-18

Compositions and methods related to antibodies that neutralize coagulase activity during disease

 #107
20190111001
2019-04-18

MICROPARTICULATE SYSTEM FOR COLONIC DRUG DELIVERY

 #108
20190100575
2019-04-04

Bispecific antigen-binding molecules that bind a target antigen and a complement component and uses thereof

 #109
20190091160
2019-03-28

Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells

 #110
20190083619
2019-03-21

METHODS AND COMPOSITIONS FOR REMOVING, REDUCING, DISPERSING, DISRUPTING OR ERADICATING BIOFILMS AND DETERMINING THE NUMBER OF BACTERIAL POPULATION IN BIOFILM OR A CULTURE CONTAINING BACTERIAL AGGREGATE

 #111
20190070281
2019-03-07

Proteins and immunizing compositions containing proteins and methods of use

 #112
20190055304
2019-02-21

Binding moieties for biofilm remediation

 #113
20190038747
2019-02-07

Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of infections

 #114
20190031766
2019-01-31

Antibody molecules to CD73 and uses thereof

 #115
20190016787
2019-01-17

Antibodies to surface determinants

 #116
20190008965
2019-01-10

Multifunctional Metal Nanoparticles Having a Polydopamine-Based Surface and Methods of Making and Using the Same

 #117
20190000971
2019-01-03

Peptides and antibodies for the removal of biofilms

 #118
20190000951
2019-01-03

materials and methods

 #119
20180369378
2018-12-27

Bacterial influence on regulation of appetite via ClpB protein mimicry of alpha-MSH

 #120
20180369355
2018-12-27

Targeting of ligand binding sites in ClfA

 #121
20180362622
2018-12-20

Compositions and methods for the therapy and diagnosis of inflammatory bowel disease

 #122
20180362621
2018-12-20

Humanized pertussis antibodies and used thereof

 #123
20180355026
2018-12-13

Method for preventing or treating nosocomial pneumonia

 #124
20180340017
2018-11-29

CD147 AS RECEPTOR FOR PILUS-MEDIATED ADHESION OF MENINGOCOCCI TO VASCULAR ENDOTHELIA

 #125
20180298084
2018-10-18

BACTERICIDAL MONOCLONAL ANTIBODY TARGETING KLEBSIELLA PNEUMONIAE

 #126
20180289803
2018-10-11

Anti-PD-L1-anti-TIM-3 bispecific antibodies

 #127
20180264097
2018-09-20

OmpA and ASP14 in vaccine compositions and as diagnostic targets

 #128
20180243392
2018-08-30

CS21 AND LNGA PROTEIN VACCINES

 #129
20180243365
2018-08-30

Peptide inhibitors of clostridium difficile toxin B (TcdB) toxin

 #130
20180221466
2018-08-09

USE OF ALPHA-TOXIN FOR TREATING AND PREVENTING STAPHYLOCOCCUS INFECTIONS

 #131
20180193457
2018-07-12

Compositions and methods for treatment and prevention of uropathogenic infection

 #132
20180169208
2018-06-21

Protective antigen complexes with increased stability and uses thereof

 #133
20180154016
2018-06-07

DE-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy

 #134
20180153991
2018-06-07

METHOD FOR THE TREATMENT OR PREVENTION OF INFECTION-RELATED IMMUNE CONDITIONS USING A COMPOSITION COMPRISING IGM

 #135
20180142001
2018-05-24

Compositions and methods for the therapy and diagnosis of inflammatory bowel disease

 #136
20180142000
2018-05-24

Anti-campylobacter jejuni antibodies and uses therefor

 #137
20180127488
2018-05-10

Antibodies that modulate immunity to drug resistant and latent MTB infections

 #138
20180125974
2018-05-10

Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria

 #139
20180118814
2018-05-03

Multi-valent hepatitis B virus antigen binding molecules and uses thereof

 #140
20180110795
2018-04-26

COMPOSITIONS AND METHODS FOR DETECTING AND TREATING PERIODONTAL DISEASE

 #141
20180105584
2018-04-19

ANTIBODY DIRECTED AGAINST IMMUNOGLOBULIN-BINDING PROTEINS OF S. AUREUS

 #142
20180085458
2018-03-29

METHODS FOR TREATING CLOSTRIDIUM DIFFICILE INFECTION AND ASSOCIATED DISEASE

 #143
20180064834
2018-03-08

Targeted enzymatic degradation of quorum-sensing peptides

 #144
20180057571
2018-03-01

Methods of treating and preventing infections and associated conditions

 #145
20180043021
2018-02-15

Anti-glucosaminidase passive immunization for infections

 #146
20180030120
2018-02-01

Anti-salmonella antibodies and uses thereof

 #147
20180028636
2018-02-01

METHODS AND COMPOSITIONS FOR EMERGENCY POST-INFECTION TREATMENT OF ANTHRAX

 #148
20180028456
2018-02-01

Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells

 #149
20180021450
2018-01-25

ANTI-STAPHYLOCOCCUS AUREUS ANTIBODY RIFAMYCIN CONJUGATES AND USES THEREOF

 #150
20180016325
2018-01-18

Anti-wall teichoic antibodies and conjugates

 #151
20170369923
2017-12-28

Methods and means for the production of Ig-like molecules

 #152
20170369864
2017-12-28

Inhibition and diagnostics of emerging tetracycline resistance enzymes

 #153
20170349648
2017-12-07

Compositions and methods for treating and preventing infections

 #154
20170342136
2017-11-30

MONOCLONAL ANTIBODY AGAINST MURAMYL PEPTIDES IN PREVENTION AND TREATMENT OF IMMUNE-MEDIATED DISEASES

 #155
20170327860
2017-11-16

Methods and means for the production of Ig-like molecules

 #156
20170274071
2017-09-28

Compositions and methods for treating Crohn's disease and related conditions and infections

 #157
20170269080
2017-09-21

OmpA in vaccine compositions and as diagnostic targets

 #158
20170258734
2017-09-14

Bacterially derived intact minicells that encompass plasmid free DNA and methods of using the same

 #159
20170252438
2017-09-07

Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists

 #160
20170246284
2017-08-31

materials and methods

 #161
20170218055
2017-08-03

Compositions and methods related to antibodies to Staphylococcal protein A

 #162
20170183397
2017-06-29

MULTI-SPECIFIC ANTI-PSEUDOMONAS PSL AND PCRV BINDING MOLECULES AND USES THEREOF

 #163
20170129943
2017-05-11

Treatment of polybacterial infections

 #164
20170129942
2017-05-11

Antibody molecule-drug conjugates and uses thereof

 #165
20170082621
2017-03-23

Methods for diagnosing and treating infection

 #166
20170066816
2017-03-09

Humanized pertussis antibodies and uses thereof

 #167
20170051047
2017-02-23

Clostridium difficile antibodies

 #168
20170044246
2017-02-16

FC-REGION VARIANTS WITH IMPROVED PROTEIN A-BINDING

 #169
20170037115
2017-02-09

Method for treating infectious diseases using a composition comprising plasma-derived immunoglobulin M (IgM)

 #170
20170035882
2017-02-09

Method for the treatment or prevention of infection-related immune conditions using a composition comprising IgM

 #171
20170015734
2017-01-19

Compositions and methods for treating and preventing infections

 #172
20170008954
2017-01-12

Monoclonal antibodies that modulate immunity to MTB and enhance immune clearance

 #173
20170008953
2017-01-12

Methods of treating and preventing infections and associated conditions

 #174
20160362481
2016-12-15

Compositions and methods for the therapy and diagnosis of inflammatory bowel disease

 #175
20160347830
2016-12-01

Immunoglobulin against the anthrax toxin

 #176
20160347828
2016-12-01

Non-HIV vaccine antigen from the vaginal microbiota capable of inducing a mucosal neutralizing protective antibody response against HIV infection

 #177
20160324950
2016-11-10

Group B polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof

 #178
20160319039
2016-11-03

Treatment of celiac disease, C. difficile infection, food intolerance and food allergy with secretory IgA/IgM

 #179
20160319037
2016-11-03

antigens

 #180
20160311925
2016-10-27

Passive immunization for infections

 #181
20160311892
2016-10-27

Anti-LPS O11 antibody

 #182
20160304566
2016-10-20

SpA5 mutant, composition comprising mutant and preparation method and use thereof

 #183
20160303213
2016-10-20

Prevention of infections by glycoprotein vaccines synthesized in

#184
20160279243
2016-09-29

Compositions and methods for treating and preventing infections

 #185
20160264650
2016-09-15

HUMAN ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINS

 #186
20160237145
2016-08-18

Binding moieties for biofilm remediation

 #187
20160228549
2016-08-11

Multifunctional metal nanoparticles having a polydopamine-based surface and methods of making and using the same

 #188
20160213778
2016-07-28

Canine health product containing antibodies against canine parvovirus type 2

 #189
20160193317
2016-07-07

PROTECTIVE ANTIGEN COMPLEXES WITH INCREASED STABILITY AND USES THEREOF

 #190
20160184450
2016-06-30

DE-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy

 #191
20160177364
2016-06-23

Methods and means for the production of Ig-like molecules

 #192
20160175441
2016-06-23

Compositions and methods related to protein A (SpA) antibodies as an enhancer of immune response

 #193
20160175440
2016-06-23

COMPOSITIONS AND METHODS FOR THE TREATMENT OF BURKHOLDERIA INFECTIONS

 #194
20160168233
2016-06-16

Cellular factors involved in the cytotoxicity of leukocidins: novel therapeutic targets

 #195
20160166690
2016-06-16

RNA-CODED ANTIBODY

 #196
20160158333
2016-06-09

METHODS FOR PRODUCING SALMONELLA O-ANTIGEN CAPSULES, COMPOSITIONS AND USES THEREOF

 #197
20160145324
2016-05-26

Antibodies directed to protective antigen

 #198
20160137749
2016-05-19

Compositions and methods related to antibodies to staphylococcal protein A

 #199
20160137724
2016-05-19

Antibodies for prevention and treatment of diseases caused by clostridium difficile

 #200
20160137723
2016-05-19

Monoclonal antibodies that react with the capsule of

#201
20160113883
2016-04-28

Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells

 #202
20160109449
2016-04-21

Antibodies or fragments thereof directed against a epitope of IsaA or IsaB

 #203
20160083457
2016-03-24

Methods and compositions for the treatment and/or prophylaxis of associated disease

 #204
20160082096
2016-03-24

Vaccine against streptococcal infections based on recombinant proteins

 #205
20160074498
2016-03-17

Compositions and methods for the treatment and prevention of Ebp pilus-related diseases

 #206
20160068591
2016-03-10

Antibodies against toxins and methods of using the same

 #207
20160051687
2016-02-25

Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells

 #208
20160039914
2016-02-11

HUMANIZED ANTIBODIES SPECIFIC FOR STAPHYLOCOCCAL ENTEROTOXIN B

 #209
20160031973
2016-02-04

Treatment of staphylococcal disorders

 #210
20160000952
2016-01-07

Targeted enzymatic degradation of quorum-sensing peptides

 #211
20150368323
2015-12-24

Anti-staphylococcal antibodies

 #212
20150353628
2015-12-10

Humanized pertussis antibodies and uses thereof

 #213
20150344548
2015-12-03

Compositions and methods for treating and preventing infections

 #214
20150335709
2015-11-26

Colostrum Composition Enriched in Anti-Endotoxin Antibodies

 #215
20150307597
2015-10-29

Anti-campylobacter jejuni antibodies and uses therefor

 #216
20150306218
2015-10-29

Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria

 #217
20150291685
2015-10-15

Antibodies to surface determinants

 #218
20150290319
2015-10-15

Antibodies against

#219
20150290168
2015-10-15

Class IIa HDAC inhibitors for the treatment of infection

 #220
20150284450
2015-10-08

COMBINATION THERAPIES USING ANTI-PSEUDOMONAS PSL AND PCRV BINDING MOLECULES

 #221
20150274814
2015-10-01

Methods of treating and preventing infections and associated conditions

 #222
20150216974
2015-08-06

Compositions And Methods Of Modulating The Immune Response

 #223
20150216967
2015-08-06

IC31 nanoparticles

 #224
20150197558
2015-07-16

BINDING MOIETIES FOR BIOFILM REMEDIATION

 #225
20150196637
2015-07-16

METHODS AND MEANS FOR THE PRODUCTION OF IG-LIKE MOLECULES

 #226
20150175681
2015-06-25

ANTIBODIES FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE-ASSOCIATED INFECTION AND DISEASE

 #227
20150175680
2015-06-25

Human antibodies against LPS derived from transgenic xenomouse

 #228
20150166641
2015-06-18

Compositions and Methods for the Removal of Biofilms

 #229
20150165015
2015-06-18

USE OF ALPHA-TOXIN FOR TREATING AND PREVENTING STAPHYLOCOCCUS INFECTIONS

 #230
20150110838
2015-04-23

Therapeutic combinations for treating Johne's disease

 #231
20150110806
2015-04-23

CD147 as receptor for pilus-mediated adhesion of to vascular endothelia

 #232
20150093389
2015-04-02

antigens

 #233
20150093384
2015-04-02

Methods and systems for multi-antibody therapies

 #234
20150064198
2015-03-05

Enhancing immunity to tuberculosis

 #235
20150050293
2015-02-19

Flagellum and anti-flagellum antibody levels in samples as a diagnostic biomarker and therapeutic target for metabolic syndrome

 #236
20150033410
2015-01-29

Methods and compositions for emergency post-infection treatment of anthrax

 #237
20150030614
2015-01-29

ANTIBODIES TO THE PCRV ANTIGEN OF PSEUDOMONAS AERUGINOSA

 #238
20150017181
2015-01-15

Prevention of infection

 #239
20150004700
2015-01-01

Rationally designed antibodies

 #240
20140356376
2014-12-04

Anti-wall teichoic antibodies and conjugates

 #241
20140356375
2014-12-04

ANTI-WALL TEICHOIC ANTIBODIES AND CONJUGATES

 #242
20140348844
2014-11-27

Neutralising antibodies to the major exotoxins TCDA and TCDB of

#243
20140335544
2014-11-13

Method of detecting the presence of an antibody in a sample

 #244
20140335095
2014-11-13

Compositions and methods related to protein A (SpA) antibodies as an enhancer of immune response

 #245
20140286960
2014-09-25

STAPHLOCOCCUS AUREUS ALPHA-HEMOLYSIN ANTIBODIES

 #246
20140271889
2014-09-18

Multifunctional metal nanoparticles having a polydopamine-based surface and methods of making and using the same

 #247
20140271670
2014-09-18

COMPOSITIONS FOR TREATING SKIN DISORDERS

 #248
20140271669
2014-09-18

Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural IgGs

 #249
20140271649
2014-09-18

METHODS AND COMPOSITIONS FOR INHIBITING STAPHYLOCOCCUS AGGLUTINATION IN BLOOD

 #250
20140271501
2014-09-18

Methods and compositions for reducing microorganisms in the oropharynx, nasopharynx and oral cavities

 #251
20140248273
2014-09-04

VACCINE BASED ON STAPHYLOCOCCAL SUPERANTIGEN-LIKE 3 PROTEIN (SSL3)

 #252
20140170134
2014-06-19

Compositions and methods related to antibodies to staphylococcal protein A

 #253
20140154265
2014-06-05

Live attenuated replication-competent arteriviruses having decreased dub/deisgylating activity

 #254
20140140999
2014-05-22

Methods and means for the production of IG-like molecules

 #255
20140127215
2014-05-08

CLOSTRIDIUM DIFFICILE ANTIGENS

 #256
20140112938
2014-04-24

Composition and method for the treatment and prevention of enteric bacterial infections

 #257
20140112937
2014-04-24

Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists

 #258
20140099328
2014-04-10

ANTIBODY PRODUCT COMPRISING N SPECIFIC ANTIBODIES

 #259
20140099320
2014-04-10

Human binding molecules having killing activity against enterococci

 #260
20140099314
2014-04-10

polypeptide and antibodies

 #261
20140072579
2014-03-13

Methods and means for the production of Ig-like molecules

 #262
20140072577
2014-03-13

Antibodies that specifically bind alpha toxin and methods of use

 #263
20140072570
2014-03-13

Antibodies or fragments thereof directed against a epitope of IsaA or IsaB

 #264
20140050731
2014-02-20

Vaccine

 #265
20140037650
2014-02-06

COMPOSITIONS AND METHODS RELATED TO ANTIBODIES TO STAPHYLOCOCCAL PROTEINS ISDA OR ISDB

 #266
20140004118
2014-01-02

antibodies

 #267
20130336981
2013-12-19

Methods and means for the production of Ig-like molecules

 #268
20130287787
2013-10-31

Monoclonal antibodies that react with the capsule of

#269
20130273074
2013-10-17

Methods and Compositions Using Anti-LPS Ligands for the Treatment and Prevention of Inflammatory Disorders

 #270
20130266583
2013-10-10

antigens

 #271
20130245234
2013-09-19

Vmp-like sequences of pathogenic

#272
20130236469
2013-09-12

Vaccine against streptococcal infections based on recombinant proteins

 #273
20130230558
2013-09-05

One dose vaccination against infections of pigs

 #274
20130230531
2013-09-05

Human antibodies to toxins

 #275
20130224216
2013-08-29

Anti-LPS enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder

 #276
20130216553
2013-08-22

Compositions and Methods for Modulation and Detection of Immune and Inflammatory Responses

 #277
20130202618
2013-08-08

Antibodies for the treatment of -associated infection and disease

 #278
20130195893
2013-08-01

Use of a pneumococcal P4 peptide for enhancing opsonophagocytosis in response to a pathogen

 #279
20130195892
2013-08-01

BVDV vaccine

 #280
20130189249
2013-07-25

Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions

 #281
20130177498
2013-07-11

METHODS AND COMPOSITIONS FOR IMMUNOTHERAPY AND DETECTION OF INFLAMMATORY AND IMMUNE-DYSREGULATORY DISEASE, INFECTIOUS DISEASE, PATHOLOGIC ANGIOGENESIS AND CANCER

 #282
20130164308
2013-06-27

specific antibodies and uses thereof

 #283
20130164302
2013-06-27

Immuno-Modulating Compositions for the Treatment of Immune-Mediated Disorders

 #284
20130156696
2013-06-20

Human antibodies against LPS

 #285
20130136746
2013-05-30

Compositions and methods related to protein A (SpA) antibodies as an enhancer of immune response

 #286
20130110249
2013-05-02

Anti-glucosaminidase passive immunization for infections

 #287
20130084292
2013-04-04

Antagonists for the prevention or treatment of inflammatory bowel disease, and more particularly of Crohn's disease

 #288
20130071428
2013-03-21

Peptides, conjugates and method for increasing immunogenicity of a vaccine

 #289
20130045211
2013-02-21

Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria

 #290
20130017203
2013-01-17

Methods of treating and preventing infections and associated conditions

 #291
20130011410
2013-01-10

Egg White Antibodies for Prevention and Treatment of Specific Localized Intestinal Infections and Diseases Associated with a Pathogenic Organism or Molecule

 #292
20120315278
2012-12-13

Human binding molecules against and

#293
20120308618
2012-12-06

1C31 nanoparticles

 #294
20120237605
2012-09-20

Multifunctional metal nanoparticles having a polydopamine-based surface and methods of making and using the same

 #295
20120230953
2012-09-13

METHODS AND COMPOSITIONS FOR IMMUNOTHERAPY AND DETECTION OF INFLAMMATORY AND IMMUNE-DYSREGULATORY DISEASE, INFECTIOUS DISEASE, PATHOLOGIC ANGIOGENESIS AND CANCER

 #296
20120219560
2012-08-30

De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy

 #297
20120171214
2012-07-05

polypeptides and antibodies

 #298
20120122238
2012-05-17

VMP-like sequences of pathogenic

#299
20120121646
2012-05-17

Vaccine

 #300
20120121581
2012-05-17

Anti-botulism antibody coformulations